A 2026 informational evaluation of MEDVi's GLP-1 weight loss program structure, compounded semaglutide and branded Ozempic ...
In addition to their weight loss benefits, GLP-1 RAs also act on neural circuits involved in appetite, impulse control, and ...
Semaglutide is helping patients achieve weight loss previously achievable only with bariatric surgery. But at what cost?
With rapid weight-loss medications transforming the way patients approach aesthetics, NicholsMD of Greenwich, the boutique dermatology and precision anti-aging destination founded by board-certified ...
Structure Therapeutics has touted the 16% weight loss—about 39 pounds—seen by aleniglipron as the best results yet for an oral GLP-1 drug, as the obesity biotech readies the candidate for phase 3. The ...
Studies in a new meta-analysis show sex differences in average weight loss, but similar benefits across other sub-groups.
Novo Nordisk's reports to the FDA spiked shortly after an inspection found the Ozempic producer ignored reports of deaths and potential side effects.
Ozempic maker's lawsuit, FDA enforcement could curtail sales of less expensive, compounded, versions of popular weight loss drugs.
Popular GLP-1 receptor agonist drugs for weight loss, also known as GLP-1 RAs, appear to be similarly effective among patients of different ages, races, and starting weights, with women benefiting ...
The Wu administration is considering dropping GLP-1 coverage for weight loss for City of Boston employees due to ...